The draft guidance states that claims referring to “mental performance,” “mental health,” “mental well-being,” “emotional balance,” “relaxation,” and “serenity” are too general.
The European Food Safety Authority (EFSA; Parma, Italy) is seeking public comment on scientific requirements for health claims related to neurological and psychological function. Comments are due by December 16, 2011.
In its draft guidance, EFSA lays out its current view on criteria, including which studies/outcome measures are appropriate for the substantiation of claims related to function and disease-risk reduction, for categories such as long-term maintenance of cognitive function, cognitive development in infants and small children, attention, memory, mood, stress, and sleep.
EFSA notes, “This draft guidance has been drawn from scientific opinions of the NDA Panel on such health claims. Thus, this guidance represents the views of the NDA Panel based on the experience gained to date with the evaluation of health claims in these areas. It is not intended that the document will include an exhaustive list of beneficial effects and studies/outcome measures that are acceptable.”
Of note, the draft guidance states:
Nutritional Outlook thanks Harry Rice, PhD, for the tip.
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.